Hurlé M A, Sánchez A, García-Sancho J
Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, Santander, Spain.
Eur J Pharmacol. 1999 Aug 27;379(2-3):191-8. doi: 10.1016/s0014-2999(99)00469-0.
The effects of micro-, delta- and kappa-opioid receptor agonists, and orphanin FQ/nociceptin (Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln), on K+-induced [Ca2+]i increase were examined in SK-N-SH cells. Exposure to K+ (50 mM) resulted in a [Ca2+]i rise, which was blocked (-85%) by furaldipine (1 microM) and increased (63%) by BayK 8644 (methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethyl-pyridine-5 -carboxylate) (0.5 microM), indicating the involvement of L-type Ca2+ channels. The kappa-opioid receptor agonists 3,4-dichloro-N-Methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide (U-50488H) (1-50 microM) and 5,7,8-N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec-8-yl]benze neacetamide (U-69593) (25 microM), and the mu-opioid receptor agonist sufentanil (100 nM-3 microM) inhibited the amplitude of K+-induced [Ca2+]i increase. The agonist of the orphan opioid receptor, orphanin FQ/nociceptin (1 microM), induced dual excitatory and inhibitory effects on the depolarisation-induced Ca2+ influx. The effects of the opioid receptor agonists were not blocked by the kappa-opioid receptor antagonist nor-binaltorphimine (1 microM), only weakly prevented by naloxone (10-100 microM) and naltrexone (100 microM), and partially prevented by pertussis toxin (100 ng/ml, 24 h). The antagonist of the orphan opioid receptor, [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 (1 microM), prevented the inhibitory effect of U-50488H, sufentanil and orphanin FQ. The present study provides pharmacological evidence for the presence of L-type Ca2+ channels in SK-N-SH cells, that are modulated by opioids through orphan opioid receptor activation.
在SK - N - SH细胞中研究了微阿片受体、δ阿片受体和κ阿片受体激动剂以及孤啡肽/痛敏肽(苯丙氨酸 - 甘氨酸 - 甘氨酸 - 苯丙氨酸 - 苏氨酸 - 甘氨酸 - 丙氨酸 - 精氨酸 - 赖氨酸 - 丝氨酸 - 丙氨酸 - 精氨酸 - 赖氨酸 - 亮氨酸 - 丙氨酸 - 天冬酰胺 - 谷氨酰胺)对钾离子诱导的细胞内钙离子浓度([Ca2+]i)升高的影响。暴露于50 mM钾离子会导致[Ca2+]i升高,该升高被1 μM的福辛普利阻断(-85%),并被0.5 μM的BayK 8644(甲基 - 1,4 - 二氢 - 2,6 - 二甲基 - 3 - 硝基 - 4 -(2 - 三氟甲基 - 吡啶 - 5 - 羧酸酯)增强(63%),表明L型钙离子通道参与其中。κ阿片受体激动剂3,4 - 二氯 - N - 甲基 - N - [2 -(1 - 吡咯烷基)环己基]苯乙酰胺(U - 50488H)(1 - 50 μM)和5,7,8 - N - 甲基 - N - [7 -(1 - 吡咯烷基)- 1 - 氧杂螺[4,5]癸 - 8 - 基]苯乙酰胺(U - 69593)(25 μM),以及μ阿片受体激动剂舒芬太尼(100 nM - 3 μM)均抑制了钾离子诱导的[Ca2+]i升高幅度。孤儿阿片受体激动剂孤啡肽/痛敏肽(1 μM)对去极化诱导的钙离子内流产生双重兴奋和抑制作用。阿片受体激动剂的作用未被κ阿片受体拮抗剂 nor - 纳洛酮啡(1 μM)阻断,仅被纳洛酮(10 - 100 μM)和纳曲酮(100 μM)微弱地抑制,并被百日咳毒素(100 ng/ml,24小时)部分抑制。孤儿阿片受体拮抗剂[苯丙氨酸1ψ(CH2 - NH)甘氨酸2]痛敏肽(1 - 13)NH2(1 μM)可阻止U - 50488H、舒芬太尼和孤啡肽/痛敏肽的抑制作用。本研究为SK - N - SH细胞中存在L型钙离子通道提供了药理学证据,这些通道通过孤儿阿片受体激活受到阿片类药物的调节。